Ferriman–Gallwey score
Ferriman–Gallwey score is a diagnostic tool used to quantify the severity of hirsutism. Hirsutism is a condition characterized by excessive hair growth in women in areas where hair is normally absent or minimal, such as the face, chest, and back. The Ferriman–Gallwey score is an important measure in the evaluation of hirsutism and plays a crucial role in diagnosing and managing conditions associated with excessive hair growth, including polycystic ovary syndrome (PCOS), adrenal hyperplasia, and other endocrine disorders.
Overview
The Ferriman–Gallwey scoring system was first introduced in 1961 by Dr. David Ferriman and Dr. John Gallwey as a method to quantify hair growth in women. The system evaluates hair growth in nine areas of the body: the upper lip, chin, chest, upper back, lower back, upper abdomen, lower abdomen, upper arms, and thighs. Each area is scored on a scale from 0 (no hair) to 4 (extensive hair growth), with the total score ranging from 0 to 36. A score of 8 or more is generally considered indicative of hirsutism.
Clinical Significance
The Ferriman–Gallwey score is widely used in clinical practice to assess the severity of hirsutism and monitor response to treatment. It is particularly useful in diagnosing conditions like PCOS, which is a common cause of hirsutism. By quantifying hair growth, healthcare providers can make informed decisions about the need for further diagnostic testing, such as hormonal assays and imaging studies, and can tailor treatment strategies to the individual's needs.
Limitations
While the Ferriman–Gallwey score is a valuable tool in the assessment of hirsutism, it has some limitations. The scoring system is somewhat subjective, as it relies on visual assessment of hair growth, which can vary between observers. Additionally, the score may not fully capture the psychological impact of hirsutism on patients, as even mild hirsutism can have significant effects on self-esteem and quality of life.
Treatment and Management
Treatment of hirsutism aims to reduce hair growth, improve cosmetic appearance, and address any underlying conditions. Options include pharmacological therapies, such as oral contraceptives and anti-androgens, and physical methods, such as laser hair removal and electrolysis. The choice of treatment depends on the severity of hirsutism, as measured by the Ferriman–Gallwey score, as well as the patient's preferences and any underlying health conditions.
Conclusion
The Ferriman–Gallwey score is a crucial tool in the evaluation and management of hirsutism. By providing a standardized method to quantify hair growth, it helps clinicians diagnose underlying conditions, assess treatment efficacy, and support patients in managing the psychological impact of excessive hair growth.
Ferriman–Gallwey score
Transform your life with W8MD's budget GLP-1 injections from $125.
W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $125 for the starting dose.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Contributors: Prab R. Tumpati, MD